Life sciences company Thermo Fisher (NYSE:TMO) reported revenue ahead of Wall Street’s expectations in Q3 CY2025, with sales up 4.9% year on year to $11.12 billion. Its non-GAAP profit of $5.79 per share was 5.3% above analysts’ consensus estimates.
Risk sentiment deteriorated sharply on Wednesday as a wave of disappointing earnings guidance and escalating U.S.-China trade tensions rattled investor confidence.
Washington D.C., October 22, 2025 – Danaher Corporation (NYSE: DHR) is currently experiencing a wave of positive sentiment, with its stock price widely expected to rise following a robust third-quarter 2025 earnings report. The life sciences and diagnostics giant exceeded analyst expectations, fueling an optimistic outlook from market experts and
Life sciences company Thermo Fisher (NYSE:TMO) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 4.9% year on year to $11.12 billion. Its non-GAAP profit of $5.79 per share was 5.3% above analysts’ consensus estimates.
Washington D.C., October 9, 2025 – The Federal Reserve finds itself navigating an increasingly complex economic landscape, attempting a delicate balancing act between taming stubbornly persistent inflation and responding to a visibly softening labor market. As of October 202025, the central bank has initiated a new cycle of interest rate
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages.
Just because a business is in the green today doesn’t mean it will thrive tomorrow.
